ESMO Breast Cancer 2026: PROs, ADCs, and immunotherapy
The Lancet Obstetrics, Gynaecology, & Women's Health · Published 2026-06-01 · DOI 10.1016/s3050-5038(26)00149-4
Authors (1)
Ben Burwood
Abstract
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Publication details
- Year
- 2026
Citation
Burwood, B. (2026). ESMO Breast Cancer 2026: PROs, ADCs, and immunotherapy. The Lancet Obstetrics, Gynaecology, & Women's Health. https://doi.org/10.1016/s3050-5038(26)00149-4
Related articles
- Depressive symptoms during the perimenopausal transition and risk of incident all-cause and cause-specific stroke in Chinese women: a prospective cohort study · The Lancet Obstetrics, Gynaecology, & Women's Health · 2026 · Same journal
- Research advances at ESMO Gynaecological Cancers 2026 · The Lancet Obstetrics, Gynaecology, & Women's Health · 2026 · Same journal
- Liver stiffness in pregnancy: pathological signal or physiological noise? · The Lancet Obstetrics, Gynaecology, & Women's Health · 2026 · Same journal
- A renewed approach to tackling medical misogyny in the UK · The Lancet Obstetrics, Gynaecology, & Women's Health · 2026 · Same journal
- Trends and future of planned egg freezing · The Lancet Obstetrics, Gynaecology, & Women's Health · 2026 · Same journal
- The hidden menopause crisis in conflict zones · The Lancet Obstetrics, Gynaecology, & Women's Health · 2026 · Same journal
- Tirzepatide, menopause hormone therapy, and oral hormone absorption · The Lancet Obstetrics, Gynaecology, & Women's Health · 2026 · Same journal
- Babies: sensitive and stunning · The Lancet Obstetrics, Gynaecology, & Women's Health · 2026 · Same journal
- Psychological burden and decision making in medically assisted reproduction: implications for patient-centred care · The Lancet Obstetrics, Gynaecology, & Women's Health · 2026 · Same journal
- Exploring microbes in women's health · The Lancet Obstetrics, Gynaecology, & Women's Health · 2026 · Same journal